Mukherjee A, Parvaiz A, Cecil T D, Moran B J
Pseudomyxoma Research Unit, North Hampshire Hospital, Hampshire, UK.
Eur J Gynaecol Oncol. 2004;25(4):411-4.
Pseudomyxoma peritonei (PMP) is a rare condition, said to be more common in females during the fourth or fifth decade of life with an incidence believed to be in the region of one per million per year. Although PMP has been reported as originating from many intra-abdominal organs, in the majority of cases an ovarian or appendix cystadenoma or cystadenocarcinoma has been implicated as the primary site. Our experience suggests that most cases arise from the appendix. We have reviewed the clinical and scientific evidence. In the four largest reported series of 393 patients, 181 (46%) were males. Immunohistochemistry techniques in women with both appendical and ovarian tumours favour an appendiceal primary in most cases. The distinction between "benign" adenomucinosis and mucinous adenocarcinoma is important in both treatment and prognosis. Experience suggests that there may well be a spectrum of disease and possibly an "adenoma carcinoma sequence".
腹膜假黏液瘤(PMP)是一种罕见疾病,据说在40至50岁女性中更为常见,据信每年发病率约为百万分之一。尽管有报道称PMP起源于许多腹腔内器官,但在大多数病例中,卵巢或阑尾囊腺瘤或囊腺癌被认为是原发部位。我们的经验表明,大多数病例起源于阑尾。我们回顾了临床和科学证据。在已报道的四个最大系列的393例患者中,181例(46%)为男性。对患有阑尾和卵巢肿瘤的女性进行免疫组织化学技术检测,在大多数病例中支持阑尾为原发部位。“良性”腺黏液瘤病和黏液腺癌之间的区分在治疗和预后方面都很重要。经验表明,很可能存在一系列疾病,甚至可能存在“腺瘤癌序列”。